358 related articles for article (PubMed ID: 23730837)
61. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection.
Heijtink RA; De Wilde GA; Kruining J; Berk L; Balzarini J; De Clercq E; Holy A; Schalm SW
Antiviral Res; 1993 Jun; 21(2):141-53. PubMed ID: 8338351
[TBL] [Abstract][Full Text] [Related]
62. Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes.
Schorr O; Borel C; Trepo C; Zoulim F; Hantz O
J Hepatol; 2006 May; 44(5):842-7. PubMed ID: 16458387
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of anti-hepadnavirus activity of Phyllanthus amarus and Phyllanthus maderaspatensis in duck hepatitis B virus carrier Pekin ducks.
Munshi A; Mehrotra R; Ramesh R; Panda SK
J Med Virol; 1993 Dec; 41(4):275-81. PubMed ID: 8106861
[TBL] [Abstract][Full Text] [Related]
64. [Experimental study on anti-DHBV effect of yu gan capsules].
Tan X; Zhang A; Yu W; Cen Y; Zhang F
Zhong Yao Cai; 2005 Aug; 28(8):679-81. PubMed ID: 16379421
[TBL] [Abstract][Full Text] [Related]
65. Effect of cantharidin, cephalotaxine and homoharringtonine on "in vitro" models of hepatitis B virus (HBV) and bovine viral diarrhoea virus (BVDV) replication.
Romero MR; Serrano MA; Efferth T; Alvarez M; Marin JJ
Planta Med; 2007 Jun; 73(6):552-8. PubMed ID: 17458779
[TBL] [Abstract][Full Text] [Related]
66. Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection.
Soni PN; Brown D; Saffie R; Savage K; Moore D; Gregoriadis G; Dusheiko GM
Hepatology; 1998 Nov; 28(5):1402-10. PubMed ID: 9794928
[TBL] [Abstract][Full Text] [Related]
67. Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.
Le Guerhier F; Thermet A; Guerret S; Chevallier M; Jamard C; Gibbs CS; Trépo C; Cova L; Zoulim F
J Hepatol; 2003 Mar; 38(3):328-34. PubMed ID: 12586299
[TBL] [Abstract][Full Text] [Related]
68. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
69. Identification of natural compounds with anti-hepatitis B virus activity from Rheum palmatum L. ethanol extract.
Li Z; Li LJ; Sun Y; Li J
Chemotherapy; 2007; 53(5):320-6. PubMed ID: 17785969
[TBL] [Abstract][Full Text] [Related]
70. [Experimental study of shuangcao granule no. 1 on duck hepatitis B virus in ducklings].
Lian Y; Tan J; Deng Z
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Jul; 20(7):530-2. PubMed ID: 11789214
[TBL] [Abstract][Full Text] [Related]
71. Characterisation of the Indian strain of duck hepatitis B virus (DHBV) and development of a carrier duck colony for antiviral drug testing.
Munshi A; Mehrotra R; Panda SK
Trop Gastroenterol; 1994; 15(2):77-85. PubMed ID: 7831721
[TBL] [Abstract][Full Text] [Related]
72. Anti-hepatitis B virus activity and mechanisms of recombinant human serum albumin-interferon-alpha-2b fusion protein in vitro and in vivo.
Bingfa X; Qinglin F; Hui H; Canjun W; Wei W; Lihua S
Pharmacology; 2009; 83(6):323-32. PubMed ID: 19407486
[TBL] [Abstract][Full Text] [Related]
73. Anti-hepatitis B virus activities of astragaloside IV isolated from radix Astragali.
Wang S; Li J; Huang H; Gao W; Zhuang C; Li B; Zhou P; Kong D
Biol Pharm Bull; 2009 Jan; 32(1):132-5. PubMed ID: 19122295
[TBL] [Abstract][Full Text] [Related]
74. Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent.
Chu CK; Boudinot FD; Peek SF; Hong JH; Choi Y; Korba BE; Gerin JL; Cote PJ; Tennant BC; Cheng YC
Antivir Ther; 1998; 3(Suppl 3):113-21. PubMed ID: 10726061
[TBL] [Abstract][Full Text] [Related]
75. Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus.
Mason WS; Cullen J; Saputelli J; Wu TT; Liu C; London WT; Lustbader E; Schaffer P; O'Connell AP; Fourel I
Hepatology; 1994 Feb; 19(2):398-411. PubMed ID: 8294097
[TBL] [Abstract][Full Text] [Related]
76. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
[TBL] [Abstract][Full Text] [Related]
77. Anti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cells.
Cui X; Inagaki Y; Xu H; Wang D; Qi F; Kokudo N; Fang D; Tang W
Biol Pharm Bull; 2010; 33(10):1728-32. PubMed ID: 20930383
[TBL] [Abstract][Full Text] [Related]
78. Anti-hepatitis B virus activities of friedelolactones from Viola diffusa Ging.
Dai JJ; Tao HM; Min QX; Zhu QH
Phytomedicine; 2015 Jul; 22(7-8):724-9. PubMed ID: 26141758
[TBL] [Abstract][Full Text] [Related]
79. [Research on the gene structure of duck hepatitis B virus and its encoding proteins].
Liu Q; Jia RY
Bing Du Xue Bao; 2012 Nov; 28(6):681-8. PubMed ID: 23367570
[TBL] [Abstract][Full Text] [Related]
80. [Research of inhibition of compound gan shu kang on hepatitis B virus].
Li HL; Cheng TY; Lu P; Cheng YL; Zhao X
Zhong Yao Cai; 2013 Jan; 36(1):93-5. PubMed ID: 23750417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]